The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of the genus Pestivirus of the family Flaviviridae, and is closely related to the viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV).
The global Classical Swine Fever Vaccines market was valued at US$ 154.7 million in 2023 and is anticipated to reach US$ 211 million by 2030, witnessing a CAGR of 4.6% during the forecast period 2024-2030.
The global classical swine fever vaccine market is dominated by Winsun, Boehringer Ingelheim and CAHIC, with the top three manufacturers accounting for about 37% of the market share. Asia Pacific is the largest market for classical swine fever vaccines, with a market share of about 70%, followed by Europe with a market share of about 15%. Tissue Culture Origin is the main type, with a share about 66%. Market Sales is the main application, which holds a share about 95%.
This report aims to provide a comprehensive presentation of the global market for Classical Swine Fever Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Classical Swine Fever Vaccines.
Report Scope
The Classical Swine Fever Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Classical Swine Fever Vaccines market comprehensively. Regional market sizes, concerning products by Source, by Sales Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Classical Swine Fever Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Source, by Sales Channel, and by regions.
Market Segmentation
By Company
- WINSUN
- Merck
- CAHIC
- Tecon
- SPAH
- Boehringer Ingelheim
- Ceva
- Harbin Veterinary Research Institute
- Qilu Animal Health Products Factory
- Ringpu Biology
- DHN
- CAVAC
- Komipharm
- Agrovet
- Bioveta
- Jinyu Bio-Technology
- Institutul Pasteur
- MVP
Segment by Source
- Tissue Culture Origin
- Cell Line Origin
Segment by Sales Channel
- Government Tender
- Market Sales
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Source, by Sales Channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Classical Swine Fever Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Classical Swine Fever Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Source, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Sales Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Classical Swine Fever Vaccines Market Overview
1.1 Product Overview and Scope of Classical Swine Fever Vaccines
1.2 Classical Swine Fever Vaccines Segment by Source
1.2.1 Global Classical Swine Fever Vaccines Market Value Comparison by Source (2024-2030)
1.2.2 Tissue Culture Origin
1.2.3 Cell Line Origin
1.3 Classical Swine Fever Vaccines Segment by Sales Channel
1.3.1 Global Classical Swine Fever Vaccines Market Value by Sales Channel: (2024-2030)
1.3.2 Government Tender
1.3.3 Market Sales
1.4 Global Classical Swine Fever Vaccines Market Size Estimates and Forecasts
1.4.1 Global Classical Swine Fever Vaccines Revenue 2019-2030
1.4.2 Global Classical Swine Fever Vaccines Sales 2019-2030
1.4.3 Global Classical Swine Fever Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Classical Swine Fever Vaccines Market Competition by Manufacturers
2.1 Global Classical Swine Fever Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Classical Swine Fever Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Classical Swine Fever Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Classical Swine Fever Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Classical Swine Fever Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Classical Swine Fever Vaccines, Product Type & Application
2.7 Classical Swine Fever Vaccines Market Competitive Situation and Trends
2.7.1 Classical Swine Fever Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Classical Swine Fever Vaccines Players Market Share by Revenue
2.7.3 Global Classical Swine Fever Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Classical Swine Fever Vaccines Retrospective Market Scenario by Region
3.1 Global Classical Swine Fever Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Classical Swine Fever Vaccines Global Classical Swine Fever Vaccines Sales by Region: 2019-2030
3.2.1 Global Classical Swine Fever Vaccines Sales by Region: 2019-2024
3.2.2 Global Classical Swine Fever Vaccines Sales by Region: 2025-2030
3.3 Global Classical Swine Fever Vaccines Global Classical Swine Fever Vaccines Revenue by Region: 2019-2030
3.3.1 Global Classical Swine Fever Vaccines Revenue by Region: 2019-2024
3.3.2 Global Classical Swine Fever Vaccines Revenue by Region: 2025-2030
3.4 North America Classical Swine Fever Vaccines Market Facts & Figures by Country
3.4.1 North America Classical Swine Fever Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Classical Swine Fever Vaccines Sales by Country (2019-2030)
3.4.3 North America Classical Swine Fever Vaccines Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Classical Swine Fever Vaccines Market Facts & Figures by Country
3.5.1 Europe Classical Swine Fever Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Classical Swine Fever Vaccines Sales by Country (2019-2030)
3.5.3 Europe Classical Swine Fever Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Classical Swine Fever Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Classical Swine Fever Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Classical Swine Fever Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Classical Swine Fever Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Classical Swine Fever Vaccines Market Facts & Figures by Country
3.7.1 Latin America Classical Swine Fever Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Classical Swine Fever Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Classical Swine Fever Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Classical Swine Fever Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Classical Swine Fever Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Classical Swine Fever Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Classical Swine Fever Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Source
4.1 Global Classical Swine Fever Vaccines Sales by Source (2019-2030)
4.1.1 Global Classical Swine Fever Vaccines Sales by Source (2019-2024)
4.1.2 Global Classical Swine Fever Vaccines Sales by Source (2025-2030)
4.1.3 Global Classical Swine Fever Vaccines Sales Market Share by Source (2019-2030)
4.2 Global Classical Swine Fever Vaccines Revenue by Source (2019-2030)
4.2.1 Global Classical Swine Fever Vaccines Revenue by Source (2019-2024)
4.2.2 Global Classical Swine Fever Vaccines Revenue by Source (2025-2030)
4.2.3 Global Classical Swine Fever Vaccines Revenue Market Share by Source (2019-2030)
4.3 Global Classical Swine Fever Vaccines Price by Source (2019-2030)
5 Segment by Sales Channel
5.1 Global Classical Swine Fever Vaccines Sales by Sales Channel (2019-2030)
5.1.1 Global Classical Swine Fever Vaccines Sales by Sales Channel (2019-2024)
5.1.2 Global Classical Swine Fever Vaccines Sales by Sales Channel (2025-2030)
5.1.3 Global Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2019-2030)
5.2 Global Classical Swine Fever Vaccines Revenue by Sales Channel (2019-2030)
5.2.1 Global Classical Swine Fever Vaccines Revenue by Sales Channel (2019-2024)
5.2.2 Global Classical Swine Fever Vaccines Revenue by Sales Channel (2025-2030)
5.2.3 Global Classical Swine Fever Vaccines Revenue Market Share by Sales Channel (2019-2030)
5.3 Global Classical Swine Fever Vaccines Price by Sales Channel (2019-2030)
6 Key Companies Profiled
6.1 WINSUN
6.1.1 WINSUN Corporation Information
6.1.2 WINSUN Description and Business Overview
6.1.3 WINSUN Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 WINSUN Classical Swine Fever Vaccines Product Portfolio
6.1.5 WINSUN Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Classical Swine Fever Vaccines Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 CAHIC
6.3.1 CAHIC Corporation Information
6.3.2 CAHIC Description and Business Overview
6.3.3 CAHIC Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 CAHIC Classical Swine Fever Vaccines Product Portfolio
6.3.5 CAHIC Recent Developments/Updates
6.4 Tecon
6.4.1 Tecon Corporation Information
6.4.2 Tecon Description and Business Overview
6.4.3 Tecon Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Tecon Classical Swine Fever Vaccines Product Portfolio
6.4.5 Tecon Recent Developments/Updates
6.5 SPAH
6.5.1 SPAH Corporation Information
6.5.2 SPAH Description and Business Overview
6.5.3 SPAH Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 SPAH Classical Swine Fever Vaccines Product Portfolio
6.5.5 SPAH Recent Developments/Updates
6.6 Boehringer Ingelheim
6.6.1 Boehringer Ingelheim Corporation Information
6.6.2 Boehringer Ingelheim Description and Business Overview
6.6.3 Boehringer Ingelheim Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Boehringer Ingelheim Classical Swine Fever Vaccines Product Portfolio
6.6.5 Boehringer Ingelheim Recent Developments/Updates
6.7 Ceva
6.6.1 Ceva Corporation Information
6.6.2 Ceva Description and Business Overview
6.6.3 Ceva Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ceva Classical Swine Fever Vaccines Product Portfolio
6.7.5 Ceva Recent Developments/Updates
6.8 Harbin Veterinary Research Institute
6.8.1 Harbin Veterinary Research Institute Corporation Information
6.8.2 Harbin Veterinary Research Institute Description and Business Overview
6.8.3 Harbin Veterinary Research Institute Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Harbin Veterinary Research Institute Classical Swine Fever Vaccines Product Portfolio
6.8.5 Harbin Veterinary Research Institute Recent Developments/Updates
6.9 Qilu Animal Health Products Factory
6.9.1 Qilu Animal Health Products Factory Corporation Information
6.9.2 Qilu Animal Health Products Factory Description and Business Overview
6.9.3 Qilu Animal Health Products Factory Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Qilu Animal Health Products Factory Classical Swine Fever Vaccines Product Portfolio
6.9.5 Qilu Animal Health Products Factory Recent Developments/Updates
6.10 Ringpu Biology
6.10.1 Ringpu Biology Corporation Information
6.10.2 Ringpu Biology Description and Business Overview
6.10.3 Ringpu Biology Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Ringpu Biology Classical Swine Fever Vaccines Product Portfolio
6.10.5 Ringpu Biology Recent Developments/Updates
6.11 DHN
6.11.1 DHN Corporation Information
6.11.2 DHN Classical Swine Fever Vaccines Description and Business Overview
6.11.3 DHN Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 DHN Classical Swine Fever Vaccines Product Portfolio
6.11.5 DHN Recent Developments/Updates
6.12 CAVAC
6.12.1 CAVAC Corporation Information
6.12.2 CAVAC Classical Swine Fever Vaccines Description and Business Overview
6.12.3 CAVAC Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.12.4 CAVAC Classical Swine Fever Vaccines Product Portfolio
6.12.5 CAVAC Recent Developments/Updates
6.13 Komipharm
6.13.1 Komipharm Corporation Information
6.13.2 Komipharm Classical Swine Fever Vaccines Description and Business Overview
6.13.3 Komipharm Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Komipharm Classical Swine Fever Vaccines Product Portfolio
6.13.5 Komipharm Recent Developments/Updates
6.14 Agrovet
6.14.1 Agrovet Corporation Information
6.14.2 Agrovet Classical Swine Fever Vaccines Description and Business Overview
6.14.3 Agrovet Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Agrovet Classical Swine Fever Vaccines Product Portfolio
6.14.5 Agrovet Recent Developments/Updates
6.15 Bioveta
6.15.1 Bioveta Corporation Information
6.15.2 Bioveta Classical Swine Fever Vaccines Description and Business Overview
6.15.3 Bioveta Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Bioveta Classical Swine Fever Vaccines Product Portfolio
6.15.5 Bioveta Recent Developments/Updates
6.16 Jinyu Bio-Technology
6.16.1 Jinyu Bio-Technology Corporation Information
6.16.2 Jinyu Bio-Technology Classical Swine Fever Vaccines Description and Business Overview
6.16.3 Jinyu Bio-Technology Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Jinyu Bio-Technology Classical Swine Fever Vaccines Product Portfolio
6.16.5 Jinyu Bio-Technology Recent Developments/Updates
6.17 Institutul Pasteur
6.17.1 Institutul Pasteur Corporation Information
6.17.2 Institutul Pasteur Classical Swine Fever Vaccines Description and Business Overview
6.17.3 Institutul Pasteur Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Institutul Pasteur Classical Swine Fever Vaccines Product Portfolio
6.17.5 Institutul Pasteur Recent Developments/Updates
6.18 MVP
6.18.1 MVP Corporation Information
6.18.2 MVP Classical Swine Fever Vaccines Description and Business Overview
6.18.3 MVP Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.18.4 MVP Classical Swine Fever Vaccines Product Portfolio
6.18.5 MVP Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Classical Swine Fever Vaccines Industry Chain Analysis
7.2 Classical Swine Fever Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Classical Swine Fever Vaccines Production Mode & Process
7.4 Classical Swine Fever Vaccines Sales and Marketing
7.4.1 Classical Swine Fever Vaccines Sales Channels
7.4.2 Classical Swine Fever Vaccines Distributors
7.5 Classical Swine Fever Vaccines Customers
8 Classical Swine Fever Vaccines Market Dynamics
8.1 Classical Swine Fever Vaccines Industry Trends
8.2 Classical Swine Fever Vaccines Market Drivers
8.3 Classical Swine Fever Vaccines Market Challenges
8.4 Classical Swine Fever Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
